ClinicalTrials.gg
TerminatedNCT03774719Updated Jul 24, 2024Results posted

Hand-carried Ultrasound to Assess Hydronephrosis

An interventional study of Hand-carried ultrasound in Hydronephrosis, Ultrasound and Acute Kidney Injury, sponsored by Washington University School of Medicine. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-24.

Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Diagnostic

Why this study was terminated
Change in staffing, COVID, New US curriculum being developed
Phase
Not applicable
Study type
Interventional
Enrollment
6
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates if trainees can accurately rule out dilation of the renal collecting system on ultrasound (hydronephrosis) using hand-carried ultrasound (HCU). Trainees will undergo a short ultrasound training program. Patients will be adults that are hospitalized and have acute or subacute kidney dysfunction. The investigators will assess sensitivity, specificity, positive and negative predictive value of HCU compared to radiology performed ultrasound, and calculate potential cost savings to the patient and to the healthcare system.

Read the detailed description

Hand-carried ultrasound is an increasingly popular imaging modality and is widely used by emergency physicians, intensivists, trauma doctors and cardiologists. Renal ultrasonography is commonly ordered for patients with acute kidney injury, with a main focus on identifying obstruction of the collecting system, a rare but potentially reversible cause of acute kidney injury.

This study's aim is to evaluate if nephrology and internal medicine trainees can accurately rule out dilation of the renal collecting system on ultrasound (hydronephrosis) using hand-carried ultrasound (HCU). Trainees will undergo a short, uniform and well described ultrasound training program. Patients will be adults that are hospitalized and have acute or subacute kidney dysfunction. The investigators will assess sensitivity, specificity, positive and negative predictive value of HCU compared to radiology performed ultrasound, and calculate potential cost savings to the patient and to the healthcare system.

02

Conditions studied

  • Hydronephrosis
  • Ultrasound
  • Acute Kidney Injury
03

In context

Hydronephrosis

55 studies on the registry are indexed under Hydronephrosis; 9 are open to participants now.

This study's enrollment of 6 is below the median of 100 across 23 interventional studies indexed under Hydronephrosis.

Browse Hydronephrosis studies →

Lead sponsor

Washington University School of Medicine is the lead sponsor of 1,803 studies on the registry; 271 are open to participants now.

Of its 329 completed or terminated interventional studies of FDA-regulated products, 216 (66%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age more than 18 years old
  • Inpatient admission to Barnes Jewish Hospital (BJH)
  • Patient has a diagnosis of Acute kidney injury (AKI) or Acute kidney Disease (AKD)
  • Renal ultrasound ordered or performed within the past 4 hours

Exclusion criteria

Exclusion Criteria:

  • End-stage renal disease
  • History of kidney transplant
  • Stable chronic kidney disease
  • Current diagnosis of renal cell carcinoma
  • Pregnant women
  • Morbid obesity ( >40)
  • Rash or active skin lesions overlying the scanning area (left or right flank)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
6 participants (actual)

Study arms

  • Experimental
    Hand-carried ultrasound arm

    This is the only arm of the study. It will be comprised of 154 inpatients who had a renal ultrasound ordered or performed within the past 4 hours. The intervention will be performing hand-carried ultrasound to evaluate for presence and degree of hydronephrosis.

    Device: Hand-carried ultrasound

Interventions

  • DeviceHand-carried ultrasound

    Hand-carried ultrasound of both kidneys to detect the presence or absence of hydronephrosis. Device used will be the lumify portable ultrasound equipped with the C5-2 curved array transducer (Philips, USA).

    Also known as: Point of care ultrasound, POCUS

06

What researchers measure

Primary outcomes

  1. Number of Participants With Absence of Hydronephrosis

    The number of participants for whom none of the kidneys imaged with hand-carried ultrasound have hydronephrosis (dilation of the collecting system) is reported

    Time frame: Through study completion, up to an average of 1 day

Secondary outcomes

  1. Direct Costs of Hand-carried Ultrasound

    Direct costs in $ of hand-carried ultrasound will be calculated and compared to the costs of radiology performed ultrasound. For hand-carried ultrasound, this will include costs of purchasing the device, training costs, yearly depreciation of the hand-carried ultrasound device. For radiology performed ultrasound, this will include the sonographer's fee, radiologist fee for interpretation of the result, transportation fee by hospital transport and depreciation of the ultrasound machine.

    Time frame: Through study completion, up to an average of 1 day

Other outcomes

  1. Ultrasound Image Quality

    Ultrasound image quality assessed by a blinded independent radiologist. The quality will be deemed either excellent, good, fair or poor by the radiologist.

    Time frame: Through study completion, up to an average of 1 day

  2. Technical Difficulty of the Ultrasound Study

    How technically difficult was it for the trainees to obtain the images (patient intubated, obesity etc.) as graded by the trainees who performed the ultrasound scans themselves. Trainees will grade difficulty using the following measurement scale (1) Technically easy: trainee able to get clear images of both kidneys within a timeframe of 10 minutes (2) Technically challenging: Trainee able to get clear images of kidneys but requiring more than 10 minutes of scanning time (3) Technically difficult: trainee unable to get clear images of both kidneys independent of time spent scanning.

    Time frame: Through study completion, up to an average of 1 day

07

Results

Posted Jul 24, 2024
Limitations and caveats
Single center, study terminated did not reach enrollment target due to change in PI and COVID pandemic. No statistical analysis was performed.

Participant flow

Participants were recruited after presenting to the hospital between May 2019 and April 2023. First participant was enrolled May 6, 2019 and last participant enrolled May 24, 2019.

Participant flow — Overall Study
MilestoneHand-carried Ultrasound Arm
Started6
Completed6
Not completed0

Outcome measures

PrimaryNumber of Participants With Absence of Hydronephrosis

The number of participants for whom none of the kidneys imaged with hand-carried ultrasound have hydronephrosis (dilation of the collecting system) is reported

Time frame:
Through study completion, up to an average of 1 day
Reported as:
Count of participants · Participants
Number of Participants With Absence of Hydronephrosis
ParticipantsHand-carried Ultrasound Arm
Number of Participants With Absence of Hydronephrosis4
SecondaryDirect Costs of Hand-carried Ultrasound

Direct costs in $ of hand-carried ultrasound will be calculated and compared to the costs of radiology performed ultrasound. For hand-carried ultrasound, this will include costs of purchasing the device, training costs, yearly depreciation of the hand-carried ultrasound device. For radiology performed ultrasound, this will include the sonographer's fee, radiologist fee for interpretation of the result, transportation fee by hospital transport and depreciation of the ultrasound machine.

Time frame:
Through study completion, up to an average of 1 day

No measurements were reported for this outcome.

Other pre-specifiedUltrasound Image Quality

Ultrasound image quality assessed by a blinded independent radiologist. The quality will be deemed either excellent, good, fair or poor by the radiologist.

Time frame:
Through study completion, up to an average of 1 day

No measurements were reported for this outcome.

Other pre-specifiedTechnical Difficulty of the Ultrasound Study

How technically difficult was it for the trainees to obtain the images (patient intubated, obesity etc.) as graded by the trainees who performed the ultrasound scans themselves. Trainees will grade difficulty using the following measurement scale (1) Technically easy: trainee able to get clear images of both kidneys within a timeframe of 10 minutes (2) Technically challenging: Trainee able to get clear images of kidneys but requiring more than 10 minutes of scanning time (3) Technically difficult: trainee unable to get clear images of both kidneys independent of time spent scanning.

Time frame:
Through study completion, up to an average of 1 day

No measurements were reported for this outcome.

Adverse events

Collected over Time from start of ultrasound evaluation to end of ultrasound evaluation, up to 2 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Hand-carried Ultrasound Arm0/6 (0%)0/6 (0%)0/6 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Hand-carried Ultrasound Arm
<=18 years0
Between 18 and 65 years3
>=65 years3
Age, Continuous
Age, Continuous(years)Hand-carried Ultrasound Arm
Median65.5 (60 to 67)
Sex: Female, Male
Sex: Female, Male(Participants)Hand-carried Ultrasound Arm
Female2
Male4
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Hand-carried Ultrasound Arm
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American1
White5
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Hand-carried Ultrasound Arm
United States6
08

Study locations

1 site
  • Barnes Jewish Hospital
    Saint Louis, Missouri 63110, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2019 to primary completion in Jun 2021, 24 months.

Results were first posted in Jul 2024, 3 years 1 month after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 7, 2018
First posted
Dec 13, 2018
StartActual
May 6, 2019
Primary completionActual
Jun 1, 2021
CompletionActual
Jun 1, 2023
Results first posted
Jul 24, 2024
Last update
Jul 24, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03774719
Responsible party
Sponsor
First posted
Dec 13, 2018
Start date
May 6, 2019
Primary completion
Jun 1, 2021
Completion
Jun 1, 2023
Results posted
Jul 24, 2024
Last update
Jul 24, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion